Atlas Trials

To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)

Clinical trial NCT05060523 · UNKNOWN

Trial details

NCT number
NCT05060523
Sponsor
Institute of Liver and Biliary Sciences, India
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver Cirrhosis
Start date
2021-09-19
Primary completion
2022-09-30
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.